Gene: CCDC124
Official Full Name: coiled-coil domain containing 124provided by HGNC
Gene Summary: Enables RNA binding activity. Predicted to be involved in transcription by RNA polymerase II. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30650 | CCDC124 Knockout cell line (HeLa) | Human | CCDC124 | 1:3~1:6 | Negative | Online Inquiry |
KO30651 | CCDC124 Knockout cell line (HCT 116) | Human | CCDC124 | 1:2~1:4 | Negative | Online Inquiry |
KO30652 | CCDC124 Knockout cell line (HEK293) | Human | CCDC124 | 1:3~1:6 | Negative | Online Inquiry |
KO30653 | CCDC124 Knockout cell line (A549) | Human | CCDC124 | 1:3~1:4 | Negative | Online Inquiry |
CCDC124 Gene Knockout Cell Lines are specialized cell models engineered to specifically disrupt the CCDC124 gene, a critical component in various cellular processes including cell proliferation and differentiation. These knockout lines are created through precise gene editing techniques, such as CRISPR-Cas9, ensuring that researchers have access to highly reliable and reproducible models for studying the gene's role in health and disease.
The primary function of these knockout cell lines is to facilitate the investigation of CCDC124's involvement in cellular pathways and its contributions to pathophysiological conditions. By eliminating the expression of this gene, researchers can analyze downstream effects on cellular behavior, signaling cascades, and gene expression profiles. This model is particularly valuable in understanding diseases where CCDC124 has been implicated, including certain cancers and developmental disorders.
Scientifically, CCDC124 Gene Knockout Cell Lines hold significant importance in both research and clinical settings. They serve as robust tools for drug discovery, biomarker validation, and functional genomics, allowing for the identification of novel therapeutic targets. Moreover, these cell lines can be utilized to develop personalized medicine approaches, particularly in cancer treatment, by elucidating how variations in the CCDC124 gene affect patient responses to therapy.
Advantageously, compared to other gene knockout options, CCDC124 Gene Knockout Cell Lines offer high specificity and efficiency in gene editing, with minimal off-target effects. This precision, combined with established protocols for cell line maintenance and experimental use, makes them an attractive option for scientists focused on cellular and molecular biology.
For researchers and clinicians looking to explore the intricacies of gene function, CCDC124 Gene Knockout Cell Lines present a powerful tool that not only enhances understanding but also paves the way for innovative research breakthroughs. Our company, renowned for its expertise in genetic engineering and cell line development, is committed to providing high-quality biological products that empower the scientific community in their quest for discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.